A detailed history of Kraft, Davis & Associates, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Kraft, Davis & Associates, LLC holds 2,566 shares of ABT stock, worth $264,811. This represents 0.08% of its overall portfolio holdings.

Number of Shares
2,566
Previous 2,714 5.45%
Holding current value
$264,811
Previous $303 Million 12.49%
% of portfolio
0.08%
Previous 0.09%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$109.52 - $120.96 $16,208 - $17,902
-148 Reduced 5.45%
2,566 $266 Million
Q4 2023

Jan 31, 2024

SELL
$90.19 - $110.4 $6,674 - $8,169
-74 Reduced 2.65%
2,714 $303 Million
Q3 2023

Oct 16, 2023

BUY
$95.53 - $114.62 $6,209 - $7,450
65 Added 2.39%
2,788 $266 Million
Q4 2022

Feb 15, 2023

BUY
$95.06 - $111.52 $258,848 - $303,668
2,723 New
2,723 $290 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $181B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Kraft, Davis & Associates, LLC Portfolio

Follow Kraft, Davis & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kraft, Davis & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kraft, Davis & Associates, LLC with notifications on news.